Latest Technology Platforms News

Computershare Limited reaffirmed its FY25 guidance at the Macquarie Australia Conference, projecting a 15% increase in management EPS supported by strong revenue growth and disciplined capital management.

XPON Technologies Group has acquired Alpha Digital for $1.72 million upfront plus performance earn-ins, immediately adding $4 million in recurring revenue and fast-tracking its path to profitability.

1414 Degrees Ltd advances its transformation into a full-service decarbonised energy provider, delivering key technology and commercial milestones in Q3 FY25 while maintaining a stable cash position.

Thrive Tribe Technologies has initiated a corporate restructure focused on revenue growth, appointed a seasoned COO, and rebranded its platform while securing venture debt funding to support expansion.

Dimerix Limited advances its Phase 3 kidney disease trial with FDA acceptance of proteinuria as a primary endpoint and clinches a lucrative licensing agreement in Japan worth up to AU$107 million plus royalties.

betr Entertainment has successfully raised $130 million through a fully underwritten equity offer priced at a 13.7% premium, underpinning its strategic acquisition of PointsBet and positioning for growth in the Australian wagering market.

Genetic Signatures Ltd reported a robust 71% jump in quarterly sales to $2.9 million, fueled by strong respiratory testing demand in Australia and key US commercial contracts. The company is advancing its automation and instrument customisation strategy to streamline molecular diagnostics offerings.

Locate Technologies Limited reported flat group revenue for Q3 FY25, with Locate2u growing 10% while Zoom2u declined 11%. The company continues to embed AI as a strategic growth and cost optimization tool.

Patrys Limited advances its PAT-DX3 therapy development for inflammatory diseases while navigating cash flow challenges and pursuing partnerships to sustain operations.

Noxopharm Limited has successfully cleared key preclinical hurdles for its SOF-SKN™ lupus drug and expanded its Sofra™ platform collaborations, supported by fresh funding to propel upcoming clinical trials.

Titomic Limited advances its strategic U.S. footprint with a new Huntsville facility set to open in June 2025, securing major defense collaborations and expanding commercial momentum in additive manufacturing.

betr Entertainment Limited has launched a fully underwritten A$130 million capital raising to fund its acquisition of a 19.9% stake in PointsBet and advance a superior takeover proposal valued at A$360 million. The move positions betr as PointsBet’s largest shareholder and challenges the existing MIXI scheme with enhanced funding certainty and synergy prospects.